English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jan 16, 2026

PhRMA senior manager on PBMs: 'Drug spending is nearly 200% higher per patient at 340B hospitals'
+ Pharmaceuticals
Patient Daily | Jan 16, 2026

Protagonist considers opting out of co-development after positive rusfertide trial results
+ Pharmaceuticals
Patient Daily | Jan 16, 2026

Novo Nordisk Foundation commits $850 million for European life sciences innovation
+ Pharmaceuticals
Patient Daily | Jan 16, 2026

Sanofi rumored to consider acquisition bid for Ocular Therapeutix
+ Pharmaceuticals
Patient Daily | Jan 16, 2026

AI helps identify new CDK9 inhibitors as potential cancer treatments
+ Pharmaceuticals
Patient Daily | Jan 16, 2026

Korro Bio seeks turnaround after clinical setback and staff reductions
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

American Lung Association praises congressional approval of EPA funding bill
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

FARE thanks Senator Durbin after new law mandates allergy training in schools

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes